Howard Edington, MD
Plastic and Reconstructive Surgery · Pittsburgh, PANPI 1568435592
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,508 of the $3,325 with a category attached, or 75.4%. Sanofi accounts for 75.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $2,561 and has fallen 91.2% since, to $225 in 2025.
Across 19 payments — averaging $175.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- E.r. Squibb & Sons, L.L.C.$546
- Novartis$129
- AbbVie$49
- Lilly USA, LLC$23
- Integra Lifesciences Corporation$22
- plus $48 from 3 others
Across 2 payments — averaging $25,145 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$50K
What the payments were for
- Consulting fees$2,50875%
- Food & beverage$81725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 1 | $2,508 |
| E.r. Squibb & Sons, L.L.C. | 6 | $546 |
| Novartis | 5 | $129 |
| AbbVie | 2 | $49 |
| Lilly USA, LLC | 1 | $23 |
| Integra Lifesciences Corporation | 1 | $22 |
| Acera Surgical, Inc. | 1 | $17 |
| Merck | 1 | $15 |
| UCB, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,325 in reported general payments places this provider in the 65th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.
See all plastic and reconstructive surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imiquimod | 37 | $487 |
| Cephalexin | 119 | $391 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $226 |
| Clindamycin Hcl | 15 | $43 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Pittsburgh
- Dinakar GollaPittsburgh$28K
- David TurerPittsburgh$15K
- Darya FadaviPittsburgh$11K
- Michael GimbelPittsburgh$8K
- Marc LiangPittsburgh$7K
- Carolyn de la CruzPittsburgh$6K
- Roy KazanPittsburgh$4K
- Craig OserPittsburgh$3K
- Justin WilliamsPittsburgh$2K
- Joseph SerlettiPhiladelphia$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.